Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2002
10/22/2002US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/22/2002US6468976 Monohydrate lisinopril
10/22/2002US6468974 Oligopeptides that provide desirable in vitro and in vivo growth hormone releasing activity and have at least one other desirable biological activity such as increased retention time
10/22/2002US6468969 Inhibition of HIV-1 replication using d-amino acid peptides
10/22/2002CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002CA2069257C Method of preparing .alpha.-l-aspartyl-l-phenylalanine methyl ester
10/17/2002WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002WO2002081694A1 Method for the sectetion and production of protein
10/17/2002WO2002081503A1 Novel substances k97-0239 and process for producing the same
10/17/2002WO2002081501A1 Crystals of proteasome-nhibitor complex
10/17/2002WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002WO2002081427A1 Novel aspartame powders
10/17/2002WO2002080858A2 Use of kpv tripeptide for dermatological disorders
10/17/2002WO2002008247A3 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
10/17/2002WO2001053330A9 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002US20020151526 Bile-acid conjugates useful for sustained release of L-DOPA, inhibitors of catechol O-methyl transferase and/or inhibitors of L-aromatic amino acid decarboxylase
10/17/2002US20020151522 Regulation of weight
10/17/2002US20020151504 Amino acid containing compounds useful as modulators of the immune system
10/17/2002US20020151502 Manufactured peptide having formula pGlu-R1-Pro, wherein R1 is Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof
10/17/2002US20020151501 Compounds having growth hormone releasing activity
10/17/2002US20020151500 Administering a therapeutically effective amount of a type-5 selective somatostatin agonist to patient
10/17/2002US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002US20020150961 Activity-dependent cysteine protease profiling reagent
10/17/2002DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/16/2002EP1249442A1 Novel arylpropionaldehyde derivatives and production and use of the same
10/16/2002EP0941218B1 Antithrombotic organic nitrates
10/16/2002EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/16/2002EP0846682B1 Penicillaminamide derivatives
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002CN1374969A FAP-activated anti-tumor compounds
10/16/2002CN1092662C Cephalosporin synthesis
10/15/2002US6465677 Method for the preparation of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester from imidazolidin-4-one intermediates
10/15/2002US6465651 Process and intermediates for growth hormone secretagogues
10/15/2002US6465615 Monohydrate lisinopril
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465432 Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
10/15/2002CA2106675C Enzymatic process for the preparation of macrolactone
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079234A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002062828A3 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/10/2002WO2002051862A3 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147361 Reacting aspartame with 3-(3-methoxy-4-hydroxyphenyl)propional
10/10/2002US20020147345 FSH mimetics for the treatment of infertility
10/10/2002US20020147311 Fusion protein for use in the treatment of tumors
10/10/2002US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002US20020147302 Liquid phase peptide synthesis of KL-4 pulmonary surfactant
10/10/2002US20020147171 Viability of organs transplants
10/10/2002US20020147151 IL-16 antagonists
10/10/2002US20020147139 Viricides
10/10/2002US20020147138 Anticancer agents
10/10/2002US20020147133 Bifunctional molecules and therapies based thereon
10/10/2002US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002US20020146718 Peptide nucleic acids for use in the treatment and prevention of viral diseases, arthritis, infection, skin, cardiovascular, gastrointestinal and kidney disorders
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/10/2002CA2442540A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2002EP1246836A2 Peptides for treatment of erectile dysfunction
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP0909176B1 Reactor and method for solid phase peptide synthesis
10/09/2002EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/09/2002EP0783521B1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/09/2002EP0772590B1 Thrombin inhibitors
10/09/2002EP0651761B1 Method for modification of recombinant polypeptides
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties
10/09/2002CN1373139A Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof
10/08/2002US6462174 Amorphous compound
10/08/2002US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment
10/08/2002US6462050 For treating or preventing venous, cardiogenic, and arterial thrombosis/embolism, athersclerosis, and for lowering propensity of devices that come into contact with blood to clot blood
10/08/2002US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/08/2002CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076490A1 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof
10/03/2002WO2002076208A1 Regulation of weight
10/03/2002WO2002066497A3 Tetrapeptide regulating prostate functions and its compositions and methods
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020142998 For prophylaxis and therapy
10/03/2002US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002US20020142967 Thrombin inhibitors
10/02/2002EP1245573A1 Aspartame derivative crystals
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002DE10116252A1 New 2-aryl-2-triorganylsilylether compounds useful for the solid phase synthesis of peptides and peptide conjugates, may be cleaved from the solid phase substrate under practically neutral conditions
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1091766C Prenyl transferase inhibitors
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 307